AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Medistim

Earnings Release • Apr 26, 2018

3662_rns_2018-04-26_a7c615bf-0d28-438e-99b0-42612cbe90ba.html

Earnings Release

Open in Viewer

Opens in native device viewer

Results for the first quarter 2018 for Medistim ASA

Sales for the quarter ended at MNOK 74.1 (MNOK 74.4). There was an increase of 5.7 % in number of procedures in USA, but sales in USA decreased with 6.3 % due to foreign exchange. Currency neutral sales of own products decreased with 2.7 %. Operating profit (EBIT) ended at MNOK 13.6 (MNOK 16.0). Medistims equipment received an updated recommendation by NICE in UK. Data collection in the REQUEST study was completed, and the first results will be presented at AATS in May. The General Meeting decided to pay a dividend of NOK 2.00 per share (NOK 1.75 per share)